Search Results - "Samara‐Kuko, Ermira"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2
  3. 3

    Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons by Tipanee, Jaitip, Di Matteo, Mario, Tulalamba, Warut, Samara-Kuko, Ermira, Keirsse, Jiri, Van Ginderachter, Jo A., Chuah, Marinee Khim, VandenDriessche, Thierry

    Published in Molecular therapy. Nucleic acids (06-03-2020)
    “…We established a semi-high-throughput in vivo screening platform using hyperactive piggyBac (hyPB) transposons (designated as PB-miR) to identify microRNAs…”
    Get full text
    Journal Article
  4. 4
  5. 5

    UNIVERSAL ALLOGENEIC CAR T CELLS ENGINEERED WITH SLEEPING BEAUTY TRANSPOSONS AND CRISPR/CAS9 FOR CANCER IMMUNOTHERAPY by Tipanee, Jaitip, Samara-Kuko, Ermira, Gevaert, Thierry, Chuah, Marinee K., VandenDriessche, Thierry

    Published in Molecular therapy (05-10-2022)
    “…Allogeneic CD19-specific chimeric antigen receptor (CAR) T cells with inactivated donor T cell receptor (TCR) expression can be used as an ‘off-the-shelf’…”
    Get full text
    Journal Article
  6. 6

    Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9 by Singh, Kshitiz, Evens, Hanneke, Nair, Nisha, Rincón, Melvin Y., Sarcar, Shilpita, Samara-Kuko, Ermira, Chuah, Marinee K., VandenDriessche, Thierry

    Published in Molecular therapy (02-05-2018)
    “…In vivo tissue-specific genome editing at the desired loci is still a challenge. Here, we report that AAV9-delivery of truncated guide RNAs (gRNAs) and Cas9…”
    Get full text
    Journal Article
  7. 7

    Gene therapy for hemophilia B using CB 2679d-GT: a novel factor IX variant with higher potency than factor IX Padua by Nair, Nisha, De Wolf, Dries, Nguyen, Phuong Anh, Pham, Quang Hong, Samara-Kuko, Ermira, Landau, Jeff, Blouse, Grant E., Chuah, Marinee K., Vanden Driessche, Thierry

    Published in Blood (27-05-2021)
    “…Sustained expression of therapeutic factor IX (FIX) levels has been achieved after adeno-associated viral (AAV) vector-based gene therapy in patients with…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12